Office of National Drug Control Policy

Budget and Performance

The National Drug Control Budget

In FY 2016, a total of $27.6 billion is requested by the President to support 2015 National Drug Control Strategy (Strategy) efforts to reduce drug use and its consequences in the United States. This represents an increase of more than $1.2 billion (4.7 percent) over the enacted FY 2015 level of $26.3 billion.

The Office of National Drug Control Policy seeks to foster healthy individuals and safe communities by promoting smart-on-crime, and evidence-based drug policy to reduce drug use and its consequences in the United States. The ONDCP's 21st century approach to drug policy represents an evidence-based plan, which balances public health and public safety efforts to prevent, treat, and support recovery from substance use disorders, and seeks to build a healthier, safer, and more prosperous country.

ONDCP Circulars 

ONDCP carries out several of its statutory authorities through instructions set forth in a series of Circulars.  These Circulars articulate the requirements in the areas of budget, performance, and policy. 

Policy Coordination (dated March 5, 2013)

The ONDCP Circular on policy coordination, pursuant to 21 U.S.C. §1704 (b), provides guidance for National Drug Control Program agencies for obtaining approval, from the Director of ONDCP, prior to initiating a change in drug policy. 

Budget Formulation (dated January 18, 2013)

This Circular provides instructions for use by National Drug Control Program agencies when preparing drug control budgets to be submitted to the Office of National Drug Control Policy for review, certification, and inclusion in the consolidated National Drug Control Budget.

Budget Execution (dated January 18, 2013)

The Budget Execution Circular provides guidance to National Drug Control Program agencies on ONDCP’s authorities related to the execution of the National Drug Control Budget.  This includes information and procedures related to reprogramming requests, the transfer of drug control funds between accounts, Fund Control Notices, and the establishment of financial plans.

Drug Control Accounting (dated January 18, 2013)

This Circular sets forth the policies and procedures to be used by National Drug Control Program agencies in conducting a detailed accounting and authentication of all funds expended on National Drug Control Program activities and the performance measures, targets, and results associated with those activities.  The reports required by this Circular are identified below.

 

Annual Accounting Report

By Statute, National Drug Control Program agencies, as outlined in the National Drug Control Strategy, are required to conduct an annual detailed accounting of all funds expended for National Drug Control Program activities. Further, this accounting is authenticated by agency Inspectors General.

 

Performance Reporting System

In accordance with the ONDCP Reauthorization Act of 2006 (P.L. 109‐469). ONDCP is required to evaluate the effectiveness of the national drug control policy and the National Drug Control Program agencies’ programs, by developing and applying specific goals and performance measurements.

The Performance Reporting System (PRS) assesses interagency progress toward achieving the goals of the National Drug Control Strategy,